Ruyssen-Witrand, Adeline http://orcid.org/0000-0002-9815-2138
Guernec, Gregory
Dupont, Julia
Lapuyade, Diane
Lioté, Frédéric
Vittecoq, Olivier
Degboé, Yannick
Constantin, Arnaud
Article History
Received: 2 June 2023
Accepted: 19 September 2023
First Online: 20 October 2023
Declarations
:
: ESPOIR cohort has been registered in ClinicalTrials.gov under the number NCT03666091). The institutional review board (ethics committee of Montpellier, France, no. 020307) approved the protocol, and all patients provided written informed consent.
: All patients provided written informed consent for participating to this study and accepted publication on the data collected.
: The authors declare no competing interests.